B2M levels and lymph node metastasis
Author Information
Author(s): Shrout J, Yousefzadeh M, Dodd A, Kirven K, Blum C, Graham A, Benjamin K, Hoda R, Krishna M, Romano M, Wallace M, Garrett-Mayer E, Mitas M
Primary Institution: Medical University of South Carolina
Hypothesis
Can molecular markers be prognostic for lymph node metastases in colorectal cancer patients?
Conclusion
Low expression of β2microglobulin (B2M) is a strong prognostic indicator of lymph node metastases in colorectal cancer patients.
Supporting Evidence
- Low B2M expression was associated with nodal metastases.
- The expression ratio of B2M/Spint2 had the highest prognostic accuracy.
- 85% sensitivity and 83% specificity were observed for nodal disease detection.
Takeaway
This study found that low levels of a gene called B2M can help doctors figure out if colorectal cancer has spread to the lymph nodes.
Methodology
The study measured the expression levels of 15 cancer-associated genes in tissue samples from colorectal cancer patients using quantitative real-time RT–PCR.
Potential Biases
Potential bias in patient selection and the reliance on specific gene expression measurements.
Limitations
The study's findings may not be generalizable to all colorectal cancer patients due to the specific sample size and selection.
Participant Demographics
Patients included 20 with lymph node metastases and 18 without, but specific demographic details are not provided.
Statistical Information
P-Value
p<0.05
Confidence Interval
95% CI=0.69–0.94
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website